Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_assertion type Assertion NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_head.
- NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_assertion description "[RA, co-administered with the dsRNA mimicker polyinosinic-polycytidylic acid (poly(I:C)), synergizes to mount a specific response program able to sense dsRNA through the concurrent upregulation of TLR3, the dsRNA helicases melanoma differentiation-associated antigen-5 (MDA-5) and RA-inducible gene-1 (RIG-1), and the dsRNA-activated protein kinase (PKR) expression, leading breast cancer cells to specifically express downstream transcriptional targets of dsRNA sensors, such as interferon-? (IFN?), interleukin-8 (IL-8), chemokine (C-C motif) ligand 5 (CCL5), and C-X-C motif Chemokine 10 (CXCL10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_provenance.
- NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_assertion evidence source_evidence_literature NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_provenance.
- NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_assertion SIO_000772 23370279 NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_provenance.
- NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_assertion wasDerivedFrom befree-20140225 NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_provenance.
- NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_assertion wasGeneratedBy ECO_0000203 NP718687.RATzuSYMpV_pcQT60fRRj-WhTTkm_4Nqj80u9ltplbAVQ130_provenance.